Equities are a key component of every investor’s portfolio, making it important to learn the fundamentals and technicals required to invest successfully and with confidence. Discover how top professional investors separate fact from fiction to maximize their profit opportunities. From explosive IPOs to solid value plays, our experts can help you formulate the right action plan for your portfolio no matter where the markets are headed.

Articles on Stocks

Companies have been transitioning their manufacturing jobs to machines for years, but we’re about to see it on a much broader scale, forecasts Sean Brodrick, a leading growth stock expert and editor of Wealth Megatrends.
Shares of Sprouts Farmers Market (SFM) rose after the company reported favorable results for the final quarter of 2020, observes Taesik Yoon, growth stock expert and editor of Forbes Investor.
Gavin Graham, contributing editor to The Income Investor, has a long career in money management and international securities, holding senior positions in financial organizations in London, Hong Kong, and Toronto; here, he looks at two London-based plays in the food and beverage sectors.
Merck (MRK), headquartered in New Jersey, is one of the largest pharmaceutical companies in the world. Its stock has a market cap near $190 billion, explains Richard Suttmeier, growth stock expert and editor of 2-Second Trader.
CEO Jeff Sprecher and his Board of Directors at Intercontinental Exchange (ICE) recently dished us a 10% dividend increase; the shares now pay $0.33 each quarter versus $0.30 previously, observes income specialist Brett Owens, editor of Hidden Yields.
Stocks opened strong Monday and continued to rally all the way into the close as President Biden's $1.9 trillion stimulus program advanced to the Senate, notes Jon Markman of Pivotal Point.
Vertex Pharmaceuticals (VRTX) is the leader in treating cystic fibrosis (CF), a hereditary disease that mainly affects the lungs. CF usually manifests quite early in life and can shorten life expectancy materially, observes Douglas Gerlach, growth stock expert and editor of Investor Advisory Service.
2021 is already shaping up as a blockbuster year. The profit opportunities have never been this big, observes Mike Larson, growth and income expert and editor of Safe Money Report.
Investing in the healthcare medical buildings sector is a great way to generate income in both good and bad times. Perhaps one of the best spaces to find great tenants is the medical field, notes Rida Morwa, income investing expert and editor of High Dividend Opportunities.
Sponsored Content - In a March 8, 2020, 60 Minutes interview, Dr. Anthony Fauci explained, “masks do not provide the protection that people think that they do.” He continued, “maybe they can block a large droplet.”

Experts on Stocks

Virtual Expos

Virtual Learning

Zhittya Genesis Medicine, Inc., is developing novel pharmaceuticals that have the potential to treat and reverse diseases that account for more than 50% of all adult deaths, worldwide. In FDA-authorized clinical trials these drugs have shown remarkable success in reversing severe coronary artery disease and healing chronic diabetic foot ulcers. New clinical trials are planned in the coming year to treat patients with Parkinson's disease, ALS (Lou Gehrig's disease), multiple sclerosis, chronic stroke, and Alzheimer's disease. A very attractive Pre-IPO investment is now being offered to suitable investors to help fund the upcoming IPO, which has a firm commitment from a highly regarded securities firm and will take place in 5-6 months.
John McCamant, editor of The Medical Technology Stock Letter, is known for helping investors pick biotech winners. Join this session to discover a unique investment opportunity in a repurposed Phase II pill, poised to treat Covid-19 by reducing viral load.
A sharp reduction in interest rates in 2020 pushed up valuations of long-duration assets, including bonds and growth stocks, to very high levels. One of the biggest risks and opportunities for multiple asset classes for the next few years is navigating the inflation cycle and the prospect of a steepening yield curve as this duration trade potentially unwinds.
A common approach among investors is to buy the dips, when accumulating stock. But does this actually work? Jonathan Hoenig, a portfolio manager and Fox News contributor, will highlight the alternative approach that's helped him best S&P 500 for over 20 years.
China was the real winner from the US presidential election. The Biden Administration is staffed by "globalists" that will resume outsourcing both manufacturing and services. Our Chinese ADRs have been hotter than not. Louis Navellier will explain which Chinese ADRs are his favorites and explain why China is expected to dominate key industries.

This presentation will discuss the catalysts behind the 2020 rally, the growing disconnect between the market and the economy, and why investors should be increasingly concerned about stocks in the Covid-impacted market. For the foreseeable future, however, equities remain the best way to generate income and grow wealthyou know how to pick the right investments.

Some of the most promising stocks today belong to a category Genia Turanova calls LIAs, or leveraged investment assets. The best of the best LIAs are a triple-treat: they can grow revenue, profits, and dividends. In this presentation, she discusses a few of her favorites.

To benefit from the long-term power of LIAs, investors must stay in the market. And the safest way is to buy market insurance through put options. Ms. Turanova explains why these vehicles are her favorite hedge and how to use them with LIAs to maximum advantage.

As conventional venture capital funds pile into the hottest start-up prospects, waiting for the IPO window isn't always a great option. We've done extremely well with "back door" offerings that bypass Wall Street, and now the rules are relaxing as regulators acknowledge that this system for matching investors with opportunities is the future. Hilary Kramer, author of the best-selling GameChanger Investing and editor of IPO Edge, has earned elite subscribers a lot of triple-digit wins in her career. Now she's eager to take those rarefied returns up another level, taking you into realms once reserved for the ultimate market insiders.
The global packaging industry is poised for materially disruptive changes that will impact markets across the spectrum from healthcare, to detergents, to consumer household products, and more. Knowing about these coming changes before they happen can help you invest ahead of the curve and reap maximum profit. Learn about the packaging technologies that are preventing second-order effects of Covid-19 and more importantly, learn about the company leading this 50-year-old revolution in global cap and closure markets in partnership with major national retailers, healthcare, and CPG companies. See why Walmart, Target, and others are jumping on board with its newest products. Milton Cohen, a CEO with several successful exits in healthcare and other sectors, leads Caring Closures International and shares how you can benefit from the coming revolution in consumer product safety.
The multi-trillion-dollar travel industry is about to undergo a major disruption as we recover from Covid-19 and as the millennial generation now becomes the major customer set. We all travel, so these upcoming changes will affect everyone. More importantly, knowing about these coming changes before they happen can help you invest ahead of the curve and reap maximum profit. Learn about the technology the industry will need to recover from Covid-19 and to serve the millennial generation. More importantly, learn about the company that has pioneered the technology that solves these problems and installed it in some of the largest Hilton and Marriott hotels in the country. Kevin Bidner, a CEO with a $500M exit in his history, who heads up The Hotel Communication Network, gives an enlightening talk about how you can get ahead of the curve and benefit from the changes to come.



While the mechanisms and machinations of the markets have changed a lot since Benjamin Graham first devised a practical method for analyzing stocks, or even since Peter Lynch racked up big wins picking equities for Fidelity's Magellan Fund, one thing remains true: companies that deliver constant profits for shareholders will see their share prices increase.

Lofty current valuations show that the easy money has already been made, and those looking to profit should be more selective going forward. So which sectors will lead the market over the months ahead? What’s the best way to limit risk in the current environment? You will find the answers to these questions and more from the top industry professionals on these pages, unlike watching the stock market news on TV. Going beyond the stock market news today, many investors are searching for investments that they can depend on. Of course, there's no such thing as a sure bet, but the top experts featured here will share the picks they think are the next best things and the sectors that are bound to thrive in the days and months ahead.

The current market environment is particularly well-suited for stock pickers and stock-trading experts—especially the experts featured here whose careers are devoted to uncovering the best opportunities available in even the most rapidly changing environment. Get easy access to the nation’s leading stock experts who regularly share their takes on where market trends are headed, where to find bargains, and how to stay ahead of the curve.

Watch videos and read articles by these experts and discover their outlooks on what’s ahead for stocks, but more importantly, identify the most compelling sectors and industry groups, as well as the specific buying opportunities for optimal growth or income. These pages are chock-full of valuable insights from our experts' varying perspectives and expertise.